Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuvation Bio Inc.NUVB · Entity 4384 | CHIEF MEDICAL OFFICER | April 17, 2026 | April 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuvation Bio Inc.
Report date April 17, 2026 · Filed April 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 18,000 |
Ending reported balance
After 2026-04-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-17 · Exercise / conversion · Acquired 50,000 · Balance 68,000 Row 2 · 2026-04-17 · Sale · Disposed 50,000 · Balance 18,000 F1: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.94 · Expires 2033-02-27 | Direct | 430,000 |
Reported balance
After 2026-04-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-17 · Exercise / conversion · Disposed 50,000 · Balance 430,000 F3: Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 430,000 Underlying: Class A Common Stock · 50,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 50,000 | $5.02 | $251,000.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 50,000 | $1.94 | $97,000.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:04 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001937915-26-000003 · form4-03042026_010341.xml · derivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 Underlying: Class A Common Stock · 150,000 shares Expires 2032-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 150,000 | $7.82 | $1,173,255.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 150,000 | $2.93 | $439,500.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · derivative · entry 6 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Class A Common Stock · 10,000 shares Expires 2032-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 10,000 | $8.00 | $80,000.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 4 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 10,000 | $3.61 | $36,100.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · derivative · entry 5 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,000 Underlying: Class A Common Stock · 10,000 shares Expires 2032-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 10,000 | $7.50 | $75,000.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 10,000 | $3.61 | $36,100.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Class A Common Stock · 20,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 20,000 | $7.00 | $140,074.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 20,000 | $1.87 | $37,400.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · derivative · entry 6 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 15,000 | $5.10 | $76,552.50 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 4 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.21. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 3,000 shares acquired on November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 15,000 | $1.87 | $28,050.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · derivative · entry 5 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 15,000 | $4.77 | $71,475.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 15,000 | $1.87 | $28,050.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $1.94 Strike: $1.94 | $38,800.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,000 Underlying: Class A Common Stock · 20,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | SaleClass A Common Stock | 20,000 | $2.50 | $50,024.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated October 10, 2024. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | Exercise / conversionClass A Common Stock | 20,000 | $1.94 | $38,800.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:33 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001415889-25-006694 · form4-03042025_110352.xml · derivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:27 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001415889-24-006286 · form4-03042024_090323.xml · derivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2034-02-27 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:56 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001209191-23-014883 · doc4.xml · derivative · entry 1 Liu Dongfang · CIK 0001937915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 21:17 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 315,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001209191-22-048153 · doc4.xml · derivative · entry 1 Liu Dongfang · CIK 0001937915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,000 Underlying: Class A Common Stock · 315,000 shares Expires 2032-08-28 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:21 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 292,500 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001209191-22-042609 · doc4.xml · derivative · entry 2 Liu Dongfang · CIK 0001937915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,500 Underlying: Common Stock · 292,500 shares Expires 2032-07-14 F2 · derivative.exercise_date: The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:21 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 490,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001209191-22-042609 · doc4.xml · derivative · entry 1 Liu Dongfang · CIK 0001937915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2032-07-14 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.